Brian A Oldham Selected Research

Dyslipidemias (Dyslipidemia)

9/2006	Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile.
5/2004	Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian A Oldham Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 12/2007 - 04/2002
4	Insulin Resistance 09/2006 - 04/2002
3	Weight Gain 12/2007 - 09/2006
3	Hyperglycemia 09/2006 - 04/2002
2	Dyslipidemias (Dyslipidemia) 09/2006 - 05/2004
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2002

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 12/2007 - 04/2002
3	Rosiglitazone (Avandia)FDA Link 12/2007 - 09/2006
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2006 - 04/2002
2	PPAR gammaIBA 12/2007 - 09/2006
2	propionic acid (potassium propionate)IBA 12/2007 - 09/2006
2	PPAR alphaIBA 05/2004 - 04/2002
1	indoleIBA 12/2007
1	LipidsIBA 05/2004
1	AcidsIBA 05/2004
1	Insulin (Novolin)FDA Link 01/2003
1	T0901317IBA 01/2003
1	LY 465608IBA 04/2002

Therapy/Procedure

1	Therapeutics 04/2002